LifePoint Health, Inc. (NASDAQ:LPNT) – Investment analysts at Oppenheimer Holdings dropped their Q4 2017 earnings per share (EPS) estimates for shares of LifePoint Health in a report issued on Tuesday. Oppenheimer Holdings analyst M. Wiederhorn now expects that the company will post earnings of $1.03 per share for the quarter, down from their prior forecast of $1.20. Oppenheimer Holdings also issued estimates for LifePoint Health’s Q2 2018 earnings at $1.05 EPS, Q4 2018 earnings at $1.22 EPS and FY2018 earnings at $4.46 EPS.

LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the business earned $0.69 earnings per share. The company’s revenue for the quarter was up .2% compared to the same quarter last year.

ILLEGAL ACTIVITY NOTICE: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2017/08/04/oppenheimer-holdings-analysts-cut-earnings-estimates-for-lifepoint-health-inc-nasdaqlpnt.html.

LPNT has been the subject of a number of other research reports. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Zacks Investment Research upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 price target for the company in a report on Thursday, July 13th. Morgan Stanley started coverage on shares of LifePoint Health in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price target for the company. Barclays PLC increased their price target on shares of LifePoint Health from $58.00 to $60.00 and gave the company an “equal weight” rating in a report on Monday, May 1st. Finally, Leerink Swann upgraded shares of LifePoint Health from a “market perform” rating to an “outperform” rating and increased their price target for the company from $73.00 to $74.00 in a report on Tuesday, June 6th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company’s stock. LifePoint Health presently has an average rating of “Hold” and a consensus target price of $66.18.

Shares of LifePoint Health (NASDAQ:LPNT) traded up 0.301% during mid-day trading on Wednesday, hitting $58.275. 160,405 shares of the stock traded hands. The firm has a market cap of $2.34 billion, a price-to-earnings ratio of 13.049 and a beta of 0.86. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95. The firm’s 50 day moving average price is $64.73 and its 200 day moving average price is $62.97.

In other LifePoint Health news, Chairman William F. Carpenter III sold 82,347 shares of the firm’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the transaction, the chairman now directly owns 504,535 shares in the company, valued at approximately $32,365,920.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the transaction, the chairman now owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The disclosure for this sale can be found here. Insiders have sold a total of 102,000 shares of company stock valued at $6,556,824 over the last 90 days. 7.28% of the stock is currently owned by insiders.

A number of institutional investors have recently bought and sold shares of LPNT. Teacher Retirement System of Texas increased its position in LifePoint Health by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock valued at $216,000 after buying an additional 9 shares during the period. US Bancorp DE increased its position in LifePoint Health by 0.8% in the second quarter. US Bancorp DE now owns 1,947 shares of the company’s stock valued at $130,000 after buying an additional 16 shares during the period. Meeder Asset Management Inc. increased its position in LifePoint Health by 0.6% in the second quarter. Meeder Asset Management Inc. now owns 13,547 shares of the company’s stock valued at $909,000 after buying an additional 76 shares during the period. Mason Street Advisors LLC increased its position in LifePoint Health by 0.7% in the first quarter. Mason Street Advisors LLC now owns 18,870 shares of the company’s stock valued at $1,236,000 after buying an additional 128 shares during the period. Finally, Amalgamated Bank increased its position in LifePoint Health by 3.0% in the first quarter. Amalgamated Bank now owns 5,946 shares of the company’s stock valued at $389,000 after buying an additional 173 shares during the period. Hedge funds and other institutional investors own 98.75% of the company’s stock.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.